CCN5 activation by free or encapsulated EGCG is required to render triple‐negative breast cancer cell viability and tumor progression
Keyword(s):
2020 ◽
2017 ◽
Vol 293
(4)
◽
pp. 1120-1137
◽
2019 ◽
Vol 29
(1)
◽
pp. 62-65
◽